A. Ernest Toth Jr.

CIK: 0001280273

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)1 (14.3%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (42.9%)

Compensation grants

Other (G, F, J, C, D, …)3 (42.9%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

AQST

Aquestive Therapeutics, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (7 total)

AQST
Aquestive Therapeutics, Inc.
May 5, 2026
Tax Payment(F)
Direct
92.7K shares at avg. $4.18$387K
AQST
Aquestive Therapeutics, Inc.
Mar 10, 2026
Sale(S)
Direct
58.3K shares at avg. $4.17$243K
AQST
Aquestive Therapeutics, Inc.
Mar 9, 2026
Award(A)
Direct
95K shares-
AQST
Aquestive Therapeutics, Inc.
Mar 9, 2025
Tax Payment(F)
Direct
8.7K shares at avg. $2.65$23K
AQST
Aquestive Therapeutics, Inc.
Mar 7, 2025
Award(A)
Performance Stock Units
Direct
82.5K shares-
AQST
Aquestive Therapeutics, Inc.
Mar 7, 2025
Award(A)
Direct
110K shares-
AQST
Aquestive Therapeutics, Inc.
Mar 7, 2025
Tax Payment(F)
Direct
10.2K shares at avg. $2.65$27K

		Type	Shares	Price		Ownership
May 5, 2026	AQST Aquestive Therapeutics, Inc.	Tax Payment(F)	92,652	$4.18	$387,285	Direct
Mar 10, 2026	AQST Aquestive Therapeutics, Inc.	Sale(S)	58,254	$4.17	$243,094	Direct
Mar 9, 2026	AQST Aquestive Therapeutics, Inc.	Award(A)	95,000	-	$0	Direct
Mar 9, 2025	AQST Aquestive Therapeutics, Inc.	Tax Payment(F)	8,736	$2.65	$23,150	Direct
Mar 7, 2025	AQST Aquestive Therapeutics, Inc.	Award(A) Performance Stock Units	82,500	-	-	Direct
Mar 7, 2025	AQST Aquestive Therapeutics, Inc.	Award(A)	110,000	-	-	Direct
Mar 7, 2025	AQST Aquestive Therapeutics, Inc.	Tax Payment(F)	10,193	$2.65	$27,011	Direct

1-7 of 7 transactions

About TOTH A ERNEST JR

TOTH A ERNEST JR (SEC CIK 0001280273) files insider reports with the SEC as SVP, Chief Financial Officer of Aquestive Therapeutics, Inc. (AQST).

Signal8 holds 4 ownership filings by TOTH A ERNEST JR, all Form 4s, filed between Mar 11, 2025 and May 7, 2026. Those filings report 7 transactions, from Mar 7, 2025 to May 5, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on TOTH A ERNEST JR's filings is in WARREN, NJ.

Recent filings by TOTH A ERNEST JR

May 5, 2026: Tax withholding of AQST shares (Form 4, code F).
Mar 10, 2026: Open-market sale of AQST shares (Form 4, code S).
Mar 9, 2026: Grant or award of AQST shares (Form 4, code A).
Mar 9, 2025: Tax withholding of AQST shares (Form 4, code F).
Mar 7, 2025: Grants or awards of AQST derivative securities (2 lines, Form 4, code A).

Other insiders filing for Aquestive Therapeutics, Inc. (AQST)

Cochran John, Director
Barber Daniel, President and CEO
Daly Richard J, Director
Korczynski Sherry, Chief Commercial Officer
Boyd Peter E., Chief People Officer
Jung Cassie, Chief Operating Officer

How to read Form 4 transaction codes